Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female~* 3 months of age and older~* Confirmed diagnosis of atopic dermatitis according to Hanifin and Rajka criteria~* Minimum of 5% BSA affected by atopic dermatitis~* ISGA score of Mild (2) or Moderate (3)~Exclusion Criteria:~- Has any clinically significant medical disorder, condition, or disease (including active or potentially recurrent non AD dermatological conditions and known genetic dermatological conditions that overlap with AD, such as Netherton syndrome).

- Gender: ALL
- Minimum Age: 3 Months
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Crisaborole 2% (Type: EXPERIMENTAL): Crisaborole 2% ointment applied once daily (QD)
- Vehicle (Type: PLACEBO_COMPARATOR): Vehicle ointment applied once daily (QD)

Based on this trial design, predict the completion outcome and termination type (if applicable).